Emergent BioSolutions (EBS) Amortization of Goodwill (2022 - 2023)
Emergent BioSolutions (EBS) recorded quarterly Amortization of Goodwill of $218.2 million in Q3 2023, up 3156.72% quarter-over-quarter from $6.7 million in Q4 2022.
Emergent BioSolutions (EBS) Amortization of Goodwill (2022 - 2023) Analysis & Trends
Emergent BioSolutions' Amortization of Goodwill history runs 2 years deep, the most recent figure standing at $218.2 million for Q3 2023.
- In Q3 2023, Amortization of Goodwill changed N/A year-over-year to $218.2 million; the TTM figure through Dec 2024 stood at $224.9 million (changed N/A YoY), while the FY2023 annual figure was $218.2 million, up 3156.72% from the prior year.
- Amortization of Goodwill was $218.2 million for Q3 2023 at Emergent BioSolutions, up from $6.7 million in the prior quarter.
- In the past five years, Amortization of Goodwill ranged from a high of $218.2 million in Q3 2023 to a low of $6.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Emergent BioSolutions | 415.46 Mn | 253.96 Mn | 84.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 218.20 Mn |
| Sep 30, 2023 | 218.20 Mn |
| Dec 31, 2022 | 6.70 Mn |
| Dec 31, 2022 | 6.70 Mn |